Skip to main content

Table 1 Co-localization coefficient of inflammasome proteins.

From: The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease

PCC

severe AD

MILD AD

MCI

HC

NLRP1+ PYCARD +

0.8ac (0.7-0.82)

0.8 de (0.7-0.82)

0.5ad (0.3-0.6)

0.4ce (0.3–0.5)

NLRP1+ CASPASE-1+

0.6 (0.4-0.7)

0.8 (0.7-0.84)

0.6 (0.4-0.65)

0.5 (0.5-0.7)

NLRP1+ CASPASE-5+

0.7bac (0.5–0.8)

0.4b (0.23-0.5)

0.3a (0.1-0.32)

0.3c (0.2-0.5)

NLRP3+ PYCARD +

0.8ac (0.6-0.82)

0.8 de (0.7-0.82)

0.6ad (0.5-0.7)

0.5ce (0.4-0.6)

NLRP3+ CASPASE-1+

0.9bac (0.8-0.9)

0.8bde (0.5-0.8)

0.5ad (0.4-0.56)

0.3ce (0.3-0.4)

NLRP3+ CASPASE-8+

0.8ac (0.7-0.85)

0.6 (0.5-0.72)

0.5a (0.3-0.55)

0.5c (0.3-0.6)

  1. Median values, interquartile range and statistical significances are presented (p <0.05)
  2. aAD vs. MCI
  3. bAD vs. MILD AD
  4. cAD vs. HC
  5. dMILD AD vs. MCI
  6. eMILD AD vs. HC
Pearson’s co-localization coefficient (PCC) of NLRP1 and NLRP3 with PYCARD, caspase-1, caspase-5 and caspase-8, in LPS-primed and Aβ42−stimulated CD14+ monocyte of patients with a diagnosis of either severe or moderate (MILD) Alzheimer’s Disease (AD) and mild cognitive impairment (MCI). Result obtained in and in age-and sex-matched healthy controls (HC) are also shown. Index reference values: PC range= −1 and +1
Back to article page

Molecular Neurodegeneration

ISSN: 1750-1326